171 related articles for article (PubMed ID: 34082508)
1. Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7.
Kong L; Wang H; Li C; Cheng H; Cui Y; Liu L; Zhao Y
Diabetes Metab J; 2021 Nov; 45(6):909-920. PubMed ID: 34082508
[TBL] [Abstract][Full Text] [Related]
2. Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation.
Cui W; Bai Y; Miao X; Luo P; Chen Q; Tan Y; Rane MJ; Miao L; Cai L
Oxid Med Cell Longev; 2012; 2012():821936. PubMed ID: 23050040
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
4. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
Bai Y; Cui W; Xin Y; Miao X; Barati MT; Zhang C; Chen Q; Tan Y; Cui T; Zheng Y; Cai L
J Mol Cell Cardiol; 2013 Apr; 57():82-95. PubMed ID: 23353773
[TBL] [Abstract][Full Text] [Related]
5. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.
Wu H; Kong L; Cheng Y; Zhang Z; Wang Y; Luo M; Tan Y; Chen X; Miao L; Cai L
Free Radic Biol Med; 2015 Dec; 89():431-42. PubMed ID: 26415026
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression.
Wang J; Tian KY; Fang Y; Chang HM; Han YN; Chen FQ
Int J Immunopathol Pharmacol; 2021; 35():20587384211034086. PubMed ID: 34344210
[TBL] [Abstract][Full Text] [Related]
9. Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.
Jiang X; Bai Y; Zhang Z; Xin Y; Cai L
Toxicol Appl Pharmacol; 2014 Sep; 279(2):198-210. PubMed ID: 24967692
[TBL] [Abstract][Full Text] [Related]
10. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
11. Delineating binding potential, stability of Sulforaphane-N-acetyl-cysteine in the active site of histone deacetylase 2 and testing its cytotoxicity against distinct cancer lines through stringent molecular dynamics, DFT and cell-based assays.
Ganai SA; Srinivasan P; Rajamanikandan S; Shah BA; Mohan S; Gani M; Padder BA; Qadri RA; Bhat MA; Baba ZA; Yatoo MA
Chem Biol Drug Des; 2021 Sep; 98(3):363-376. PubMed ID: 33966346
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification.
Su X; Wang S; Zhang H; Yang G; Bai Y; Liu P; Meng L; Jiang X; Xin Y
J Cell Mol Med; 2021 May; 25(9):4408-4419. PubMed ID: 33793066
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
Paul B; Li Y; Tollefsbol TO
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
16. HDAC1 Promotes Myocardial Fibrosis in Diabetic Cardiomyopathy by Inhibiting BMP-7 Transcription Through Histone Deacetylation.
Ouyang C; Huang L; Ye X; Ren M; Han Z
Exp Clin Endocrinol Diabetes; 2022 Oct; 130(10):660-670. PubMed ID: 35760306
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic weapons in plant-herbivore interactions: Sulforaphane disrupts histone deacetylases, gene expression, and larval development in Spodoptera exigua while the specialist feeder Trichoplusia ni is largely resistant to these effects.
Somers DJ; Kushner DB; McKinnis AR; Mehmedovic D; Flame RS; Arnold TM
PLoS One; 2023; 18(10):e0293075. PubMed ID: 37856454
[TBL] [Abstract][Full Text] [Related]
18. HDAC dependent transcriptional repression of Bmp-7 potentiates TGF-β mediated renal fibrosis in obstructive uropathy.
Manson SR; Song JB; Hruska KA; Austin PF
J Urol; 2014 Jan; 191(1):242-52. PubMed ID: 23820056
[TBL] [Abstract][Full Text] [Related]
19. BMP7-induced-Pten inhibits Akt and prevents renal fibrosis.
Higgins DF; Ewart LM; Masterson E; Tennant S; Grebnev G; Prunotto M; Pomposiello S; Conde-Knape K; Martin FM; Godson C
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3095-3104. PubMed ID: 28923783
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
